SCIEX, a specialist in life science analytical technologies, appointed Inese Lowenstein as the new president of SCIEX, replacing Jean-Paul Mangeolle, who is retiring.
In her new role, Lowenstein will focus on accelerating innovation driven by a deep understanding of customer needs, while further improving the commercial execution to provide researchers with premier end-to-end MS-based solutions to enable customers to obtain life-changing answers faster.
Joe Fox, who most recently held the role of VP of Separations, is now appointed Senior VP of Global Sales, Service and Digital Marketing, a position Lowenstein previously held with SCIEX.
Since joining SCIEX in August 2016 as Senior VP, Global Sales and Service, Lowenstein has demonstrated her passion for people by creating an engaged culture, spearheading the establishment of the first-ever SCIEX Diversity & Inclusion Council and serving as its Executive Champion.
Lowenstein came to SCIEX with nearly 25 years of experience and a very strong leadership background in Sales, Marketing, Product Management and General Management, with more than 20 of those years served in science-related industries.
Lowenstein is a pioneer in the STEM fields (science, technology, engineering, and mathematics) and prior to joining SCIEX, she held roles of increasing responsibility at Merck and EMD Millipore, most recently as an Executive VP, Head of Display Materials Business Unit, Performance Materials.
Lowenstein holds a Bachelor of Engineering Science from Riga Technical University, Latvia and an MBA from Walter A. Haas School of Business, University of California at Berkeley.
According to a 2014 US Bureau of Labor Statistics report, women comprise 53% of biological scientists, 52% of medical scientists, but only 39% of chemists and material scientists and 28% of environmental scientists and geoscientists. In addition to these statistics, women have not seen employment growth in STEM careers since 2000.
“For more than 40 years, SCIEX has been working with scientists and lab analysts to provide them with revolutionary mass spectrometry-based technologies and solutions that enable us to see the future of well-being differently,” said Lowenstein.
“SCIEX is a diverse company with a reputation that scientists trust and rely on for their analytical research, drug discovery and development, clinical diagnostics and routine testing needs. I look forward to continuing our mission to help improve the world in which we live, while improving diversity and inclusion within STEM careers.”
